Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

Five years of adjuvant tamoxifen therapy for estrogen receptor (ER) -positive breast cancer is more effective than 2 years of use. However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer. Within s...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical oncology Ročník 26; číslo 4; s. 549
Hlavní autori:	Owusu, Cynthia, Buist, Diana S M, Field, Terry S, Lash, Timothy L, Thwin, Soe Soe, Geiger, Ann M, Quinn, Virginia P, Frost, Floyd, Prout, Marianne, Yood, Marianne Ulcickas, Wei, Feifei, Silliman, Rebecca A
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.02.2008
Predmet:	Aged Aged, 80 and over Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - pathology Female Humans Life Tables Lymphatic Metastasis Medical Records - standards Neoplasm Recurrence, Local - prevention & control Neoplasm Staging Patient Compliance - statistics & numerical data Receptors, Estrogen - metabolism Selective Estrogen Receptor Modulators - administration & dosage Tamoxifen - administration & dosage Treatment Outcome
ISSN:	1527-7755, 1527-7755
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!